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The incidence of fetal tumors has been increased due to generalization of prenatal evaluation 
and improvement of imaging techniques. The early detection of a fetal tumor and understanding 
of its imaging features are very important for fetal, maternal, and neonatal care. Ultrasonography 
is usually used for the detection and differential diagnosis of fetal tumors, and magnetic 
resonance imaging is increasingly being used as a complementary study. Many fetal tumors have 
different clinical and imaging features compared with pediatric tumors. Although several fetal 
tumors may mimic other common anomalies, some specific imaging features may carry early 
accurate diagnosis of fetal tumors, which may alter the prenatal management of a pregnancy 
and the mode of delivery, and facilitate immediate postnatal treatment.
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Introduction
Although the prevalence of all congenital tumors was reported as the range of 1.7-13.5 per 100,000 
live births, the true prevalence may be much higher because many cases of stillborn or aborted may 
not be reported [1-4]. Recent study reported higher incidence of congenital tumors [1], probably due 
to generalization of prenatal evaluation and improvement of imaging techniques.
The diagnosis of a fetal mass is a diagnostic and management dilemma because of the variety of 
possible differential diagnoses and the variable course during intrauterine and neonatal period [5,6]. 
The most challenging problem is to decide which case may be appropriate to ultrasonography (US) 
monitoring and postnatal surgery. The accurate prenatal diagnosis of a fetal tumor and the prediction 
for the need of prenatal intervention or immediate postnatal treatment is often impossible [5-8]. 
Many fetal tumors are not seen until relatively late during pregnancy and often as incidental findings 
in the late second or third trimester [7,9].
The prognosis of fetal tumor is generally poor, although there are some exceptions. Not only the 
histology of fetal tumors but also the location and size are important factors of the prognosis of 
fetal tumors. Some benign tumors are also fatal when tumors are large and causing cardiovascular 
compromise or airway obstruction.
The characteristics of fetal tumors are markedly different from those of pediatric tumors. Fetal US findings of fetal tumors
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tumors have different prevalence, locations, histologic features, 
and biologic behavior compared with pediatric tumors. The early 
detection of a fetal neoplasm and understanding of its imaging 
features are very important for fetal, maternal, and neonatal care. 
US is usually used as the first imaging modality for the detection 
and differential diagnosis of fetal tumors. Color Doppler US (CDUS) 
and Doppler spectrum analysis is helpful for understanding of 
the pathophysiology of fetal tumors and the accompanying fetal 
hemodynamic changes. Magnetic resonance imaging (MRI) is 
increasingly being used as a complementary study. The purpose of 
this review is to describe the prenatal imaging findings and clinical 
characteristics of relatively common fetal tumors categorized by 
their locations and origins.
Fetal Brain Tumors
Fetal intracranial tumors are rare, accounting for 0.5% to 1.9% of 
all pediatric tumors [10-14]. The most common fetal brain tumor 
is teratoma, followed by astrocystoma, craniopharyngioma, and 
primitive neuroectodermal tumor [15]. Fetal intracranial tumors are 
detected usually during the third trimester. Most are associated with 
a poor prognosis [10-15]. Such tumors can cause spontaneous 
intracranial hemorrhage or dystocia during delivery. 
Teratoma is the most common congenital neoplasm composed of 
tissues originating from all three germinal layers, and may occur in a 
variety of locations. Fetal brain teratoma usually appears as a large, 
solid and/or cystic tumor, often replacing normal brain tissue (Fig. 1) 
and sometimes eroding the skull [16]. Most fetuses with prenatally 
diagnosed intracranial teratomas die before or shortly after birth. 
The prognosis worsens with increasing tumor size and decreasing 
gestational age at diagnosis [16-19].
Most fetal astrocytomas occur at the supratentorial posterior 
cranial fossa. Fetal astrocytomas range from benign to malignant 
tumors [15]. Glioblastoma accounts for 2%-9% of congenital 
brain tumors [10] and 60% of fetal brain astrocytoma [15]. On 
the prenatal US, glioblastoma appears as a large homogeneous 
hyperechoic mass involving the supratentorial cerebral parenchyma 
[20]. Mass effect and hydrocephalus are usually accompanied. 
The prevalence of hemorrhage in congenital glioblastoma has 
been reported as 18%, which is much higher than in children and 
adults [10]. The rapid growth of congenital glioblastoma may be 
related to this higher incidence of bleeding, which explains the poor 
prognosis of glioblastomas. In a few reported cases, the cause of 
immediate death was heart failure due to anemia resulting from 
the sequestration of a large amount of blood by the highly vascular 
tumor [21]. 
Fetal intracranial hemorrhage usually mimics brain tumors (Fig. 
2). In many instances, the differential diagnosis between intracranial 
tumor and hematoma is impossible, but several findings may be 
helpful in the differential diagnosis. Hematoma is usually well-
demarcated and shows decrease in size and change in echo pattern 
at the follow-up US exams. 
Tumors of the Fetal Face and Neck
Fetal tumors of the face and neck are a diverse group of lesions. 
Fig. 1. Ultrasonography (US) findings of fetal brain teratoma in a 21-week fetus.
A. A huge solid and cystic mass (arrows) in the posterior cranial fossa is replacing and compressing the cerebral hemispheres (asterisk). B. 
Color Doppler US shows prominent blood flows in the mass.
A BJeong Yeon Cho, et al.
242   Ultrasonography 33(4), October 2014  e-ultrasonography.org
Vascular lesions including lymphangioma and hemangioma are 
common, but these two lesions may be considered as congenital 
malformations rather than true neoplasm [22]. Teratoma of face and 
neck is relatively uncommon compared with lymphangioma, but is 
a true neoplasm. The prognosis of teratoma usually depends on the 
size and location of the tumor related with airway obstruction. 
There are four histological types of lymphangioma including 
capillary lymphangioma, cavernous lymphangioma, cystic 
hygroma, and vasculolymphatic malformation [23]. These types are 
considered to be a spectrum of a same pathologic process. Most 
lymphangiomas occur in the neck, generally in the posterior triangle. 
US may demonstrate unicameral or multilocular cystic masses with 
thin or thick-walled septa (Fig. 3). Scattered low-level echoes, a 
solid component, or fluid-fluid levels, all due to bleeding and fibrin 
deposition may occur [24]. The internal border of a lymphangioma 
is usually indistinct and diffuse infiltration may occur [25]. Cystic 
hygroma usually appears as an isolated malformation and the 
remainder of the lymphatic system is normal. However, a fetal 
Fig. 2. Ultrasonography (US) findings of intracranial hematoma in a 29-week fetus.
A. The axial US image shows a large mixed echogenic mass (arrow) in the left side of cerebral hemisphere. The falx cerebri (arrowhead) 
is shifted to right. These findings are very similar to brain tumor, but the margin of the mass is much better defined. B. The coronal power 
Doppler US image demonstrates no blood flow in the mass.
A B
Fig. 3. Ultrasonography (US) findings of fetal lymphangiomas in a 27-week fetus.
A. The coronal US image of the other fetus shows a multi-septated cystic mass (arrow) in the left side of fetal neck. B. The axial Color Doppler 
US image reveals no blood flow in the mass (arrow).
A BUS findings of fetal tumors
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nuchal cystic hygroma has a poor prognosis when associated with 
chromosomal abnormalities and fetal hydrops.
Teratomas of face and neck may originate from the thyrocervical 
area, palate, or nasopharynx, and often appear as bulky masses 
containing both cystic and solid elements. Calcifications are present 
in only 50% of cases and may not be obvious at US [26]. Cervical 
teratomas often involve the thyroid gland, although they do not 
arise directly from thyroid tissue [4]. Cervical teratomas are usually 
large at the first detection and may extend to all directions. They 
may cause marked hyperextension of the fetal neck, resulting in 
dystocia. Fetal oropharyngeal teratoma is also known as epignathus 
and is easily detected by prenatal US [27]. It usually appears as a 
large solid and cystic mass the anterolateral aspect of the fetal face 
and neck. A stalk of mass is attached to the palate through oral 
cavity (Fig. 4). Intracranial extension of the mass is not uncommon 
and the prognosis is not good in such cases. Because of the difficulty 
in swallowing of amniotic fluid, one-third of these tumors are 
associated with polyhydramnios [28]. Neonatal survival depends on 
the size and extent of the involved tissues, respiratory compromise 
being the major cause of morbidity and mortality. Untreated 
cervical teratomas are associated with a high mortality rate, though 
after surgical removal the chances of survival are excellent. There 
have been several reports [29-31] that the ex utero intrapartum 
treatment (EXIT) procedure has increased survival rates of fetuses 
with obstructing neck mass to 69%-92%. In the EXIT procedure, 
the fetus is partially delivered by cesarean section and undergoes 
intubation or surgical procedures while the placenta and umbilical 
cord remain intact. 
Tumors of the Fetal Chest
Tumors in fetal chest are very rare condition, but various tumors can 
develop in fetal chest and heart. Lymphangioma and hemangioma 
may also be found in the axillae and mediastinum. The US findings 
are not different to those of cervical tumors.
Congenital infantile fibrosarcoma is a very rare mesenchymal 
tumor that is primarily developed in the soft tissue of distal 
extremities and occasionally in unusual locations such as the 
lung and heart [32,33]. Prenatal diagnosis may be possible from 
26 weeks of gestation by US and MRI, but congenital infantile 
fibrosarcoma is usually diagnosed as hemangioma.
Congenital cardiac tumors are rare, with a prevalence of 0.01%-
0.05% [34]. Rhabdomyoma is the most common cardiac tumor 
in infants and children, accounting for 60% to 86% [34,35] 
followed by fibroma, teratoma, myxoma, and hemangioma. 
However, differential diagnosis between these tumors is difficult. 
Rhabdomyoma may occur as a single or multiple lesions within 
the ventricles and may be detected prenatally. More than 
50% is associated with tuberous sclerosis [36]. The majority of 
rhabdomyomas are discovered incidentally at routine obstetrical 
US, whereas a few are discovered in patients with a family history 
of tuberous sclerosis or fetal cardiac arrhythmia, or in association 
with nonimmune hydrops. On the prenatal US, rhabdomyoma 
appears as a homogeneous, echogenic, intracardiac mass, and is 
Fig. 4. Prenatal ultrasonography (US) and magnetic resonance imaging (MRI) findings of fetal oropharyngeal teratoma in a 32-week 
fetus.
A. The sagittal US image shows a lobulated solid and cystic mass (arrow) with tiny calcifications in front of the fetal face. B. Fetal MRI reveals 
a large solid and cystic mass (black arrows) in front of the fetal face and a stalk (arrowhead) abutting to the palate. The mass also shows 
marked intracranial extension (white arrows). 
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most commonly located in the ventricle, especially at the ventricular 
septum (Fig. 5). Cardiac rhabdomyomas are often multiple, occurring 
in more than one cardiac chamber and may produce arrhythmias, 
obstruct blood flow in the heart, or diminish contractility [37]. 
Although cardiac tumors can easily be detected by prenatal US at 
as early as 20 weeks of gestation, diagnosis requires that they are 
of sufficient size. During the fetal period cardiac rhabdomyomas 
are known to either become larger or regress, but most regress 
postnatally, either partially or completely [37]. Fetal tuberous 
sclerosis is usually diagnosed with multiple cardiac rhabdomyomas, 
but prenatal detection of subependymal hamartoma (Fig. 6) is not 
easy in many cases. Renal cysts and angiomyolipomas are detected 
after birth in most of cases.   
Tumors of the Fetal Liver
Liver tumors represent approximately 5% of all congenital tumors [4]. 
A wide variety of both benign and malignant neoplasms can develop 
in the fetal liver including hemangioendothelioma, mesenchymal 
hamartoma, hepatoblastoma, hepatocellular adenoma, and 
metastases [4]. The imaging findings of fetal hepatic tumors may 
widely overlap, the early detection and prenatal follow up of these 
tumors are very important for fetal, maternal, and postnatal care.
The histogenesis of benign vascular liver tumors is not completely 
clear, which has led to some confusion in terminology. In the 
literature, vascular tumors are variably described as hemangioma, 
infantile hemangioma, hepatic arteriovenous malformation, and 
infantile hemangioendothelioma [22]. Although hemangioma is 
the most common benign hepatic tumor, prenatal diagnosis liver 
hemagioma has rarely been reported [38,39]. The true incidence of 
fetal hepatic hemangioma was certainly underestimated because 
this tumor is often uncomplicated and resolves spontaneously during 
the first two years of life. On prenatal US, hepatic hemangioma 
usually appears as a well-circumscribed abdominal mass with 
ranging in diameter from 1 to 10 cm. It may be solitary or 
multiple. Multiple liver hemangiomas sometimes appear as part of 
generalized hemangiomatosis syndrome. The internal structure is 
generally heterogeneous, with hypoechoic areas located at center, 
and both hypo- and hyperechogenicity may be observed. CDUS 
may show vascular flow with low resistive index (Fig. 6) [38,39]. 
The mortality rate in infantile hepatic hemangioma has been 
reported as 12%-90%. Complications include congestive cardiac 
failure, thrombocytopenia, and intra-abdominal hemorrhage as a 
consequence of rupture of the hemangioma [40]. 
Mesenchymal hamartoma is a benign liver tumor composed 
of large, fluid-filled cysts surrounded by loose mesenchymal 
tissue containing small bile ducts [41]. It usually appears as a 
predominantly cystic or mixed echogenic mass and should be a 
primary consideration in the differential diagnosis of an enlarging 
cystic liver lesion [22]. Prenatal US finding of mesenchymal 
hamartoma widely overlaps with that of hepatic hemangioma. 
Usually it does not have increased vascularity at CDUS [42,43].
Hepatoblastoma is the most common congenital hepatic 
malignancy, but it is less common during fetal life than hemangioma 
or mesenchymal hamartoma [4]. Hepatoblastoma usually appear 
as a well-defined echogenic lesion, which may have a spoke-
Fig. 5. Ultrasonography (US) findings of cardiac rhbdomyomas in a 34-week fetus with tuberous sclerosis.
A. Four chamber view of fetal heart shows echogenic masses at the interventricular sepum (arrow) and in the left and right ventricles 
(arrowheads). B. The coronal US image of fetal brain reveals lower echoic hamartomas at the frontal subependymal areas of bilateral lateral 
ventricles (arrows). 
A BUS findings of fetal tumors
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Tumors of the Fetal Kidney and Adrenal Gland
About 5% of perinatal tumors develop from the kidney. The 
most of perinatal renal tumor is mesoblastic nephroma. Fetal or 
perinatal Wilms tumor and rhabdoid tumor are very rarely reported 
[4]. Mesoblastic nephroma is a rare benign mesenchymal renal 
tumor, arising either from the kidney or the renal fossa. Fetal 
mesoblastic nephroma occurs exclusively during the third trimester. 
Mesoblastic nephromas tend to be large, involving at least half of 
the kidney, and are well circumscribed although not encapsulated 
(Fig. 7). Rapid enlargement of the mass may lead to hemorrhage. 
Mesoblastic nephroma is frequently associated with polyhydramnios 
wheel appearance [44]. Calcifications and pseudo-capsule may be 
common features of hepatoblastoma [4]. The prognosis of perinatal 
hemangioma is very poor and complications, including intrapartum 
rupture, hemorrhage, hydrops, and metastases, are common [4].
Hepatocellular adenoma in the fetus is very rare and its 
radiological findings have not been extensively described. These 
tumors are generally round masses with variable echogenicity, and 
are clearly distinguishable from normal liver parenchyma. They are 
usually quite large, and infarction, hemorrhage and rupture are 
frequent. At postnatal computed tomography and MRI, internal 
hemorrhage, fatty change, or necrosis may be observed.
A B
Fig. 6. Prenatal and postnatal imaging features of hepatic hemangioendothelioma in a 36-week fetus.
A. Coronal ultrasonography (US) image shows a low-echogenic large mass (arrows) with lobulated contour in the fetal liver. B. Color Doppler 
US image shows prominent blood flows (arrows) at the periphery of the mass. C. T2 weighted magnetic resonance image reveals a large 
mass (arrows) with high signal intensity in the fetal liver. D. Postnatal contrast-enhanced computed tomography taken at arterial phase 
reveals a large liver mass with peripheral bright enhancement (arrows). 
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and consequently with premature labor. The cause of the 
polyhydramnios is not fully understood [4,22]. Another associated 
abnormality is hypercalcemia [4,45], which may cause polyuria and 
polyhydramnios [43]. The prognosis after surgical excision is usually 
good. On prenatal US, mesoblastic nephroma usually appears as a 
well-defined large homogeneous mass with preserved contour of 
involved kidney. CDUS usually shows increased blood flow, which 
may lead to fetal hydrops in some cases [4,46].
Neuroblastoma is the most common malignant tumor in 
neonates, accounting for 20% of all such malignancies [47]. More 
than 90% of fetal neuroblastomas develop in the adrenal gland, 
while only 35% of pediatric cases occur in adrenal gland [48,49]. 
Fetal neuroblastomas are usually detected in the third trimester of 
pregnancy and are typically suprarenal and right sided [50,51]. The 
US findings are variable, ranging from pure cystic to solid and small 
to large masses (Fig. 8). Small fetal neuroblastoma usually appears 
as a hyperechoic mass [49,51,52], which should be distinguished 
from extralobar pulmonary sequestration (Fig. 9) or perirenal fat 
tissue [50]. Overall prognosis of fetal neuroblastoma is excellent, 
and this may be due in part to the detection of an otherwise 
clinically silent neuroblastoma in situ, which would undergo 
spontaneous regression [53]. It may be appropriate to avoid overly 
aggressive therapeutic interventions, especially when many favorable 
prognostic indicators are present at diagnosis. 
Tumors of the Fetal Pelvic Cavity
Sacrococcygeal teratoma is the most common congenital neoplasm. 
The prevalence was reported as one in 40,000 live births with a 
female preponderance of 4:1 [4]. The fetal prevalence is most likely 
higher, considering the high number of in utero deaths, stillbirths, or 
terminated pregnancies that may go underreported [22]. It usually 
A B
Fig. 7. Prenatal and postnatal imaging findings of mesoblastic 
nephroma in a 35-week fetus.
A. A large heterogeneous mass (arrows) is replacing the lower two 
third of the right kidney (asterisk). B. Color Doppler ultrasonography 
reveals prominent blood flows in the mass. C. Contrast-enhanced 
computed tomography taken one week after birth reveals a huge 
mass replacing almost portion of the right kidney.
CUS findings of fetal tumors
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Fig. 9. Comparison of prenatal ultrasonography (US) findings of small neuroblastoma (A) and extralobar pulmonary sequestration (B). 
A. The axial US image of a 32-week fetus shows a round echogenic mass (arrow) at the right adrenal gland. A part of adrenal gland 
is obliterated by the mass (arrowhead). B. The coronal US images of a 32-week fetus show an echogenic mass (arrow) at the left 
subdiaphragmatic area, mimicking neuroblastoma. Abutting left adrenal gland (AD) and kidney (LK) are intact. 
A B
A B
RK
Fig. 8. Prenatal ultrasonography (US) and magnetic resonance 
imaging (MRI) findings of neuroblastomas in a 27-week fetus.
A. The axial image of fetal abdomen shows a large heterogeneously 
echogenic mass (arrow) in the left posterior abdomen and a small 
homogeneously hyperechoic mass (arrowhead) anterior to the right 
kidney (RK). B. The sagittal US image shows a large heterogeneous 
mass (arrows) in left posterior abdomen of the fetus. C. Fetal MRI 
reveals two masses (arrows) in bilateral anterior perirenal spaces. 
CJeong Yeon Cho, et al.
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appears as a large midaxial exophytic mass at the perineum. It may 
be almost entirely external (type I), internal and external in equal 
parts (type II), mainly internal (type III), or entirely internal (type 
IV) [54]. At prenatal US, the majority of those tumors are seen as a 
solid, or mixed cystic and solid, external caudal mass (Figs. 10, 11). 
Only small proportions are entirely cystic [55]. A sacrococcygeal 
teratoma may cause significant perinatal morbidity and mortality, 
and may lead to various complications such as severe dystocia, 
fetal hydrops, polyhydramnios, or bleeding during parturition. Due 
to vascular steal from high metabolic demand and secondary high-
output cardiac insufficiency, the prognosis for fetuses with solid 
tumor is usually poor [56]. The mirror syndrome is a life-threatening 
condition with maternal fluid retention and hemodilution mimicking 
severe preeclampsia [57], which occurs in the setting of hydrops 
fetalis and manifests as progressive maternal edema “mirroring” 
that of the sick fetus. 
Rhabdomyosarcoma is the most common soft-tissue tumor in 
children, but very rare in fetuses. The most common locations are the 
Fig. 10. Prenatal ultrasonography (US) findings of a large sacrococcygeal teratoma in a 21-week fetus.
A. The sagittal US image shows a large mainly cystic protruding mass (arrow) at the perineum of the fetus. B. Color Doppler US reveals subtle 
blood flows at the solid portion of the mass.
A B
Fig. 11. Prenatal ultrasonography (US) and magnetic resonance imaging (MRI) findings of mainly intrapelvic sacrococcygeal teratoma 
in a 24-week fetus.
A. A lobulated contour multi-septated cystic mass (arrow) at the perineum of the fetus. B. Sagittal T2-wighted magnetic resonance image 
reveals a multi-septated cystic mass at the anterior portion of the sacrum and coccyx. 
A BUS findings of fetal tumors
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head and neck (41%), the genitourinary tract and the abdominal 
cavity (34%) and the trunk or extremities (25%) [58]. Prenatal US 
may reveals a large echogenic soft-tissue mass replacing the normal 
tissues (Fig. 12) [59]. Differential diagnosis from other soft tissue 
tumors, such as teratoma and fibrosarcoma, is usually impossible 
and postnatal biopsy is necessary. The prognosis depends on the 
stage of the disease, age, the primary site, and subtype of the tumor. 
The embryonal subtype is most common in children and has the best 
prognosis, but all have a poor prognosis if they occur in perinatal 
period and are in an advanced stage [59,60].
Conclusion
Although tumors rarely occur during the fetal life, variety of tumors 
can be detected in each fetal organ. Fetal tumors are usually 
different in their histologic characteristics, anatomic distribution, 
pathophysiology, and biologic behavior compared with those of 
the same tumors in children. The routine antenatal US exams have 
increased detection and diagnosis of fetal tumors and MRI may 
be helpful for the differential diagnosis in some cases. Although 
several fetal tumors may mimic other common fetal anomalies, 
some specific imaging features may carry early accurate diagnosis of 
fetal tumors. It is very important for the diagnostic physician to be 
familiar with imaging features and pathophysiological characteristics 
of fetal tumors, which may alter the prenatal management of a 
pregnancy and the mode of delivery, and facilitate immediate 
postnatal treatment.
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A B
Fig. 12. Prenatal ultrasonography (US) and magnetic resonance 
imaging (MRI) findings of rhabdomyosarcoma at the pelvis of a 
36-week fetus. 
A. A sagittal US image of fetal pelvis shows a large mass (arrows) in 
front of the sacrum and coccyx mimicking intrapelvic solid teratoma. 
B. Color Doppler US shows prominent vascular flows in the mass. C. 
T2-weighted magnetic resonance image reveals a well-demarcated 
solid mass (arrows) at the posterior portion of the lower pelvic 
cavity. UB, urinary bladder.
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